Folate and Vitamin B-12 and Risk of Fatal Cardiovascular Disease: Cohort Study from Busselton, Western Australia

Overview

Journal BMJ

Specialty General Medicine

Date 2003 Jan 18

PMID 12531843

Citations 10

Authors

Joseph Hung

John P Beilby

Matthew W Knuiman

Mark Divitini

Affiliations

Soon will be listed here.

Abstract

Objective: To test the hypothesis that the incidence of fatal coronary heart disease and cardiovascular disease in a general population is related to serum and red cell folate and vitamin B-12 concentrations.

Design: Cohort study with follow up of 29 years.

Setting: Busselton, Western Australia.

Participants: 1419 men and 1531 women aged 20 to 90 years, who were alive more than three years after their participation in the 1969 Busselton health survey. 2314 (78.4%) had no cardiovascular disease at the initial survey.

Main Outcome Measures: Hazard ratios for fatal coronary heart disease and cardiovascular disease in men and women according to baseline concentrations of serum and red cell folate and serum vitamin B-12.

Results: 213 men and 159 women died from coronary heart disease, and 342 men and 302 women died from cardiovascular disease. Serum and red cell folate concentrations showed a moderate positive correlation (r=0.26, P<0.001) but otherwise serum and red cell folate and serum B-12 concentrations were not strongly correlated with each other or with other standard risk factors. After age and standard risk factors were adjusted for, there was no independent association between folate and B-12 concentrations and death from coronary heart disease or cardiovascular disease in the full cohort or the subcohort with no cardiovascular disease at baseline. The multivariate adjusted hazard ratio for death from cardiovascular disease in the lowest versus the highest category of red cell folate concentration was 1.05 (95% confidence interval 0.77 to 1.43) in men and 1.10 (0.81 to 1.51) in women.

Conclusions: These findings do not support the hypothesis that lower folate and B-12 concentrations increase the risk of fatal cardiovascular disease in a general population. The routine use of these vitamins for preventing cardiovascular disease should await evidence from clinical trials.

Citing Articles

Association between RBC folate and diabetic nephropathy in Type2 diabetes mellitus patients: a cross-sectional study.

Yu P, Ji Y, Wang H, Liu K Sci Rep. 2024; 14(1):24692.

PMID: 39433832 PMC: 11494071. DOI: 10.1038/s41598-024-76456-0.

Red blood cell folate level is associated with periodontitis in American adults: results from the NHANES 2009-2014.

Liu Z, Luo S, Jiao R, Li W, Jin F, Sun J BMC Oral Health. 2024; 24(1):825.

PMID: 39034420 PMC: 11265046. DOI: 10.1186/s12903-024-04599-7.

Associations between homocysteine and B vitamins and stroke: a cross-sectional study.

Zhang P, Xie X, Zhang Y Front Neurol. 2023; 14:1184141.

PMID: 37456629 PMC: 10339286. DOI: 10.3389/fneur.2023.1184141.

Nonlinear associations of serum cobalamin with risk of all-cause and cardiovascular mortality in hypertensive adults.

Zhu X, Tang Y, Cheang I, Gao R, Liao S, Yao W Hypertens Res. 2023; 46(5):1276-1286.

PMID: 36805030 DOI: 10.1038/s41440-023-01218-w.

Folate Status and Mortality in US Adults With Diabetes: A Nationally Representative Cohort Study.

Xiong H, Li X, Cheng S, Chen P, Guo S, Huang X Front Cardiovasc Med. 2022; 9:802247.

PMID: 35548409 PMC: 9082538. DOI: 10.3389/fcvm.2022.802247.

References

Voutilainen S, Rissanen T, Virtanen J, Lakka T, Salonen J . Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study. Circulation. 2001; 103(22):2674-80. DOI: 10.1161/01.cir.103.22.2674. View

Eikelboom J, Lonn E, Genest Jr J, Hankey G, Yusuf S . Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999; 131(5):363-75. DOI: 10.7326/0003-4819-131-5-199909070-00008. View

Lonn E . Do antioxidant vitamins protect against atherosclerosis? The proof is still lacking*. J Am Coll Cardiol. 2001; 38(7):1795-8. DOI: 10.1016/s0735-1097(01)01626-6. View

Welborn T, Cumpston G, Cullen K, CURNOW D, McCall M, STENHOUSE N . The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol. 1969; 89(5):521-36. DOI: 10.1093/oxfordjournals.aje.a120965. View

Millbank L, Davis R, Rawlins M, Waters A . Automation of the assay of folate in serum and whole blood. J Clin Pathol. 1970; 23(1):54-9. PMC: 474414. DOI: 10.1136/jcp.23.1.54. View

Cullen K . Mass health examinations in the Busselton population, 1966 to 1970. Med J Aust. 1972; 2(13):714-8. DOI: 10.5694/j.1326-5377.1972.tb103506.x. View

Selhub J, Jacques P, Wilson P, Rush D, Rosenberg I . Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993; 270(22):2693-8. DOI: 10.1001/jama.1993.03510220049033. View

Ubbink J . Vitamin nutrition status and homocysteine: an atherogenic risk factor. Nutr Rev. 1994; 52(11):383-7. DOI: 10.1111/j.1753-4887.1994.tb01369.x. View

Boushey C, Beresford S, Omenn G, Motulsky A . A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995; 274(13):1049-57. DOI: 10.1001/jama.1995.03530130055028. View

10.

Knuiman M, Jamrozik K, Welborn T, Bulsara M, Divitini M, Whittall D . Age and secular trends in risk factors for cardiovascular disease in Busselton. Aust J Public Health. 1995; 19(4):375-82. DOI: 10.1111/j.1753-6405.1995.tb00389.x. View

11.

Morrison H, Schaubel D, Desmeules M, Wigle D . Serum folate and risk of fatal coronary heart disease. JAMA. 1996; 275(24):1893-6. DOI: 10.1001/jama.1996.03530480035037. View

12.

Chasan-Taber L, Selhub J, Rosenberg I, MALINOW M, Terry P, Tishler P . A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 1996; 15(2):136-43. DOI: 10.1080/07315724.1996.10718578. View

13.

Knuiman M, Vu H . Risk factors for stroke mortality in men and women: The Busselton Study. J Cardiovasc Risk. 1996; 3(5):447-52. DOI: 10.1177/174182679600300506. View

14.

Knuiman M, Vu H . Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health. 1998; 51(5):515-9. PMC: 1060537. DOI: 10.1136/jech.51.5.515. View

15.

Rimm E, Willett W, Hu F, Sampson L, Colditz G, Manson J . Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998; 279(5):359-64. DOI: 10.1001/jama.279.5.359. View

16.

. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration. BMJ. 1998; 316(7135):894-8. PMC: 28491. View

17.

Folsom A, Nieto F, McGovern P, Tsai M, MALINOW M, Eckfeldt J . Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998; 98(3):204-10. DOI: 10.1161/01.cir.98.3.204. View

18.

Ford E, Byers T, Giles W . Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol. 1998; 27(4):592-8. DOI: 10.1093/ije/27.4.592. View

19.

MALINOW M, Bostom A, Krauss R . Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999; 99(1):178-82. DOI: 10.1161/01.cir.99.1.178. View

20.

Knuiman M, Vu H, Bartholomew H . Multivariate risk estimation for coronary heart disease: the Busselton Health Study. Aust N Z J Public Health. 1999; 22(7):747-53. DOI: 10.1111/j.1467-842x.1998.tb01487.x. View